Rhenman & Partners Asset Management AB as of Sept. 30, 2014
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 99 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson call | 4.3 | $15M | 140k | 106.59 | |
| Alkermes (ALKS) | 3.3 | $11M | 266k | 42.87 | |
| Universal Health Services (UHS) | 3.0 | $10M | 99k | 104.50 | |
| Biogen Idec (BIIB) | 2.8 | $9.6M | 29k | 330.79 | |
| Alexion Pharmaceuticals | 2.8 | $9.6M | 58k | 165.83 | |
| Salix Pharmaceuticals | 2.5 | $8.4M | 54k | 156.24 | |
| Medtronic | 2.4 | $8.3M | 134k | 61.95 | |
| Gilead Sciences (GILD) | 2.2 | $7.7M | 72k | 106.44 | |
| Celgene Corporation | 2.2 | $7.6M | 80k | 94.78 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $6.6M | 92k | 72.16 | |
| Covidien | 1.9 | $6.6M | 76k | 86.51 | |
| Abbvie (ABBV) | 1.9 | $6.4M | 111k | 57.76 | |
| Nektar Therapeutics (NKTR) | 1.8 | $6.1M | 508k | 12.07 | |
| Thermo Fisher Scientific (TMO) | 1.7 | $6.0M | 49k | 121.69 | |
| NPS Pharmaceuticals | 1.7 | $5.8M | 224k | 26.00 | |
| CVS Caremark Corporation (CVS) | 1.7 | $5.7M | 72k | 79.58 | |
| Rite Aid Corporation | 1.6 | $5.4M | 1.1M | 4.84 | |
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $5.4M | 219k | 24.76 | |
| Incyte Corporation (INCY) | 1.5 | $5.2M | 107k | 49.05 | |
| Bristol Myers Squibb (BMY) | 1.5 | $5.1M | 99k | 51.18 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $4.8M | 43k | 112.30 | |
| Actavis | 1.4 | $4.8M | 20k | 241.30 | |
| Regeneron Pharmaceuticals (REGN) | 1.3 | $4.6M | 13k | 353.69 | |
| Pharmacyclics | 1.3 | $4.5M | 38k | 117.42 | |
| Cardinal Health (CAH) | 1.3 | $4.4M | 59k | 74.92 | |
| Intercept Pharmaceuticals In | 1.3 | $4.4M | 19k | 236.67 | |
| Community Health Systems (CYH) | 1.3 | $4.3M | 79k | 54.78 | |
| McKesson Corporation (MCK) | 1.2 | $4.3M | 22k | 194.68 | |
| Dex (DXCM) | 1.2 | $4.2M | 106k | 39.99 | |
| WellPoint | 1.2 | $4.2M | 35k | 119.60 | |
| Hca Holdings (HCA) | 1.2 | $4.1M | 58k | 70.52 | |
| Catamaran | 1.1 | $3.9M | 93k | 42.15 | |
| AmerisourceBergen (COR) | 1.1 | $3.9M | 50k | 77.30 | |
| Merck & Co (MRK) | 1.1 | $3.9M | 65k | 59.28 | |
| Medivation | 1.1 | $3.8M | 38k | 98.87 | |
| Thoratec Corporation | 1.0 | $3.6M | 134k | 26.73 | |
| St. Jude Medical | 1.0 | $3.4M | 57k | 60.12 | |
| Amgen (AMGN) | 0.9 | $3.2M | 23k | 140.48 | |
| Teva Pharmaceutical Industries (TEVA) | 0.9 | $3.2M | 59k | 53.75 | |
| UnitedHealth (UNH) | 0.9 | $3.0M | 35k | 86.26 | |
| Abiomed | 0.9 | $3.0M | 121k | 24.83 | |
| Allergan | 0.9 | $2.9M | 17k | 178.18 | |
| Masimo Corporation (MASI) | 0.8 | $2.9M | 135k | 21.28 | |
| Aetna | 0.8 | $2.8M | 35k | 81.00 | |
| Allscripts Healthcare So conv | 0.8 | $2.8M | 210k | 13.41 | |
| Express Scripts Holding | 0.8 | $2.8M | 39k | 70.64 | |
| Celladon | 0.8 | $2.7M | 257k | 10.46 | |
| Clovis Oncology | 0.8 | $2.6M | 57k | 45.37 | |
| Boston Scientific Corporation (BSX) | 0.7 | $2.5M | 214k | 11.81 | |
| Centene Corporation (CNC) | 0.7 | $2.5M | 30k | 82.70 | |
| C.R. Bard | 0.7 | $2.4M | 17k | 142.71 | |
| Mednax (MD) | 0.7 | $2.4M | 44k | 54.82 | |
| Cerner Corporation | 0.7 | $2.4M | 40k | 59.58 | |
| Insulet Corporation (PODD) | 0.7 | $2.3M | 63k | 36.85 | |
| Ariad Pharmaceuticals | 0.7 | $2.3M | 423k | 5.40 | |
| ISIS Pharmaceuticals | 0.7 | $2.3M | 58k | 38.83 | |
| Hologic (HOLX) | 0.6 | $2.2M | 90k | 24.33 | |
| Cyberonics | 0.6 | $2.2M | 43k | 51.16 | |
| PAREXEL International Corporation | 0.6 | $2.1M | 34k | 63.09 | |
| Aegerion Pharmaceuticals | 0.6 | $2.2M | 65k | 33.38 | |
| AmSurg | 0.6 | $2.1M | 42k | 50.05 | |
| Endologix | 0.6 | $2.1M | 200k | 10.60 | |
| Orexigen Therapeutics | 0.6 | $2.1M | 494k | 4.26 | |
| Edwards Lifesciences (EW) | 0.6 | $2.0M | 20k | 102.15 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $2.0M | 149k | 13.71 | |
| CareFusion Corporation | 0.6 | $2.0M | 45k | 45.24 | |
| Hyperion Therapeutics | 0.6 | $2.0M | 80k | 25.22 | |
| Esperion Therapeutics (ESPR) | 0.6 | $2.0M | 83k | 24.46 | |
| Revance Therapeutics (RVNC) | 0.6 | $2.0M | 105k | 19.33 | |
| CIGNA Corporation | 0.6 | $2.0M | 22k | 90.68 | |
| Cepheid | 0.6 | $2.0M | 45k | 44.02 | |
| Infinity Pharmaceuticals (INFIQ) | 0.6 | $2.0M | 148k | 13.42 | |
| Achillion Pharmaceuticals | 0.6 | $2.0M | 200k | 9.98 | |
| Eli Lilly & Co. (LLY) | 0.6 | $1.9M | 30k | 64.87 | |
| ImmunoGen | 0.6 | $1.9M | 180k | 10.59 | |
| Keryx Biopharmaceuticals | 0.6 | $1.9M | 136k | 13.75 | |
| NuVasive | 0.6 | $1.9M | 54k | 34.87 | |
| AFLAC Incorporated (AFL) | 0.5 | $1.9M | 32k | 58.25 | |
| Supernus Pharmaceuticals (SUPN) | 0.5 | $1.8M | 212k | 8.69 | |
| Ligand Pharmaceuticals In (LGND) | 0.5 | $1.8M | 39k | 47.00 | |
| Celldex Therapeutics | 0.5 | $1.8M | 138k | 12.96 | |
| Macrogenics (MGNX) | 0.5 | $1.8M | 85k | 20.91 | |
| Dynavax Technologies Corporation | 0.5 | $1.8M | 1.2M | 1.43 | |
| Stryker Corporation (SYK) | 0.5 | $1.7M | 21k | 80.76 | |
| Jazz Pharmaceuticals (JAZZ) | 0.5 | $1.6M | 10k | 160.60 | |
| Tesaro | 0.4 | $1.5M | 55k | 26.93 | |
| Sunesis Pharmaceuticals | 0.4 | $1.4M | 201k | 7.14 | |
| Array BioPharma | 0.4 | $1.4M | 379k | 3.57 | |
| Auxilium Pharmaceuticals note | 0.4 | $1.3M | 45k | 29.85 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $1.0M | 13k | 78.13 | |
| Bind Therapeutics | 0.3 | $932k | 109k | 8.59 | |
| Exelixis (EXEL) | 0.2 | $765k | 500k | 1.53 | |
| Anthera Pharmaceutcls | 0.2 | $768k | 400k | 1.92 | |
| Omnicare | 0.2 | $623k | 10k | 62.30 | |
| Volcano Corporation | 0.1 | $470k | 44k | 10.63 | |
| Threshold Pharmaceuticals | 0.1 | $439k | 122k | 3.61 | |
| Lexicon Pharmaceuticals | 0.1 | $416k | 295k | 1.41 | |
| Sorrento Therapeutics (SRNEQ) | 0.1 | $328k | 73k | 4.52 | |
| Endocyte | 0.1 | $300k | 49k | 6.09 |
